Dalmia Group Launches "Coronavirus Preventive Capsule" for Prevention Against COVID-19
Dalmia Group is launching Herbal Composition "dhl Coronavirus
Preventive Capsule" for prevention against COVID-19. The
medicine will be launched on 16th March 2020 in New Delhi India
Dalmia Centre for Research and Development (DCRD),
after many years of extensive research developed a polyherbal combination of 15
herbs called Astha -15 and we have derived dhl Coronavirus preventive capsule
from the same composition and all the important herbs mentioned in the Indian
System of Medicine. dhl Coronavirus preventive capsule originally as
Astha-15 has undergone a randomized double blind, placebo-controlled study on
patients Speciality Govt. Hospital for Thoracic medicine, Chennai, India under
the watchful eyes of internationally recognized respiratory physicians who
followed a peer reviewed ethically approved clinical protocol to assess the
efficacy of dhl Coronavirus in comparison to the modern medicines.
The unique blend of 15 herbs involved in dhl Coronavirus provide
immunity to the person. It also acts as a bronchodilator, decongestant,
anti-inflammatory and lung detoxifier. According to the double-blind study
using DCBT4567 – dhl Coronavirus, it was found that the patients tested had significant
reduction (95% significance) in dyspnoea, wheezing cough, expectoration,
disability and sleep disturbances. dhl Coronavirus which was originally taken
from the brand Astha-15 did not exhibit any of the side-effects normally
observed with allopathic drugs.
COVID-19 also known as Coronavirus has affected more than 87,000 people
across the world. It has flu like symptoms which includes running nose, cough,
fever, body pain and breathlessness. Lungs are exposed to approximately 7000
litres of air every day. The viruses being air-borne are inhaled through the
nose and reaches the lungs where it attacks the cell machinery and starts the
replication thus lowering the immunity of the host and causing flu-like
symptoms in the body. The breathlessness caused by the virus is also due to the
loss of the lining of the alveolar cells.
Herbs and plants naturally contain many active chemicals and thus drugs
derived from such sources can have multiple health benefits when administered
to patients. Due to the presence of multiple active compounds in
phytomedicines, they are an ideal candidate for treating conditions with a
variety of symptoms such as inflammatory diseases which affect multiple systems.
Herbal medicine-derived natural products can be considered as an
alternative therapeutic potential for respiratory diseases since several
compounds showed anti-inflammatory effects inhibition different inflammatory
mediators involved in respiratory diseases.
It is believed that the natural products derived from plants inhibit the
pulmonary inflammation by the inhibition of the transcription of NF-κB to the
nucleus, thus preventing the development of all the inflammatory processes
triggered by allergen, cigarette smoke, virus, or bacteria. Therefore, herbal
supplements can reduce the inflammatory cytokines release and oxidative stress.
These effects together culminate with the improvement of lung function and with
the reduction of pulmonary inflammation.
Most of the studies are pointing out the effects of natural products on
the inhibition of NF-κB and MAPK pathways, besides the antioxidant effects
associated with these products.
No comments
Subscribe To Comment